BACKGROUND Hepatocellular carcinoma is the most common type of primary liver cancer.
Treatment choice is dependent on underlying liver dysfunction and cancer stage. Treatment …

Background Selective internal radiation therapy (SIRT) is applied to hepatocellular
carcinoma (HCC), a disease with increased incidence in the elderly. However, SIRT has …

Although hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide [1], it
is particularly important in the Asia-Pacific because of the high prevalence of chronic viral …

Transarterial radioembolization (TARE) is a form of brachytherapy in which intra-arterially
injected yttrium-90-loaded microspheres serve as a source for internal radiation purposes …

PURPOSE: To present the findings of a risk-stratification survival analysis with use of data
collected on a heterogeneous group of patients with hepatocellular carcinoma (HCC) …

Purpose In light of recently published clinical reports and trials, the TheraSphere Global
Dosimetry Steering Committee (DSC) reconvened to review new data and to update …

Background. In patients with hepatocellular carcinoma, selection criteria for transarterial
hepatic selective internal radiotherapy are imprecise. Additionally, radiographic parameters …

Purpose To evaluate the differences in safety, effectiveness, and dosimetry between glass-
based and resin-based ablative yttrium-90 (90 Y) transarterial radioembolization (TARE) of …

Streamlining TARE or personalizing SIRT? Different philosophies to treat different HCCs with
Yttrium-90… Page 1 1 Streamlining TARE or personalizing SIRT? Different philosophies to …

Aim: Several techniques for radionuclide therapy of hepatocellular carcinoma (HCC) have
been developed. In this overview the available radionuclide treatment modalities for HCC …